NR 568 Midterm Reviewer 117 complete
solutions.
NR 568 Midterm Reviewer 117 complete
solutions.
Penicillin Monitoring - ANSWER Renal impairment because it can accumulate if the kidney is not working
that could cause toxic levels.
Penicillin high risk patients - ANSWER history of severe allergic reactions to penicillin, cephalosporin or
carbapenems
Penicillin evalutation of therapeutic effects - ANSWER reduction of symptoms like fever, edema, pain
and inflammation
Cephalosporin therapeutic goal - ANSWER treatment of infection that is caused by susceptible organism
Cephalosporin baseline data - ANSWER Take samples for culture to identify the infecting organism
Ceph Monitoring - ANSWER None . No routine lab monitroing is suggested.
Ceph high risk patients - ANSWER history of allergic reactions to ceph, pcn and carbapenem
Ceph evaluation of therapy - ANSWER reduction of symptoms like fever, pain, edema and inflammation
Ceph miniminize adverse effects - ANSWER Because it can promote C-diff instruct patients to report
increase in stool frequency.
Carbapenems baseline - ANSWER take sample for culture to determine infecting organism
Carbapenems monitoing - ANSWER None. Nothing is recommended.
, NR 568 Midterm Reviewer 117 complete
solutions.
Carbapenems high risk patients - ANSWER history of allergic reaction
patient using valprotate to control seizure should never be given imipenem
Carbapenems evaluation - ANSWER decrease on symptoms like fever, pain, edema and inflammation
Carbapenems minimize adverse effects - ANSWER dosage should be reduced for patients with renal
impairment to prevent toxicity
Vancomycin therapeutic goal - ANSWER Treatment of serious infections, including C-diff, MRSA, and
infections that are caused by susceptible organisms in patients allergic to PCN.
Vanco baseline - ANSWER culture and sensitivity
Vanco monitoring - ANSWER Vanco drug levels should be monitored during IV treatment
Vanco high risk patients - ANSWER patients with renal impairment
Vanco evaluating therapeutic effects - ANSWER monitor for indeication of antimicrobial effects,
including reduction in fever, pain, edema and inflammation.
What do you not administer with Tetracycline? - ANSWER Calcium supplements
MIlk products
Iron supplements
Magnesium-containing laxatives
most antacids (bec of content of magnesium or aluminum)
What do you teach a patient taking Tetracycline? - ANSWER To apply sunscree, protective clothing and
avoid exposure to sunlight because this medication can cause severe sunburn.
solutions.
NR 568 Midterm Reviewer 117 complete
solutions.
Penicillin Monitoring - ANSWER Renal impairment because it can accumulate if the kidney is not working
that could cause toxic levels.
Penicillin high risk patients - ANSWER history of severe allergic reactions to penicillin, cephalosporin or
carbapenems
Penicillin evalutation of therapeutic effects - ANSWER reduction of symptoms like fever, edema, pain
and inflammation
Cephalosporin therapeutic goal - ANSWER treatment of infection that is caused by susceptible organism
Cephalosporin baseline data - ANSWER Take samples for culture to identify the infecting organism
Ceph Monitoring - ANSWER None . No routine lab monitroing is suggested.
Ceph high risk patients - ANSWER history of allergic reactions to ceph, pcn and carbapenem
Ceph evaluation of therapy - ANSWER reduction of symptoms like fever, pain, edema and inflammation
Ceph miniminize adverse effects - ANSWER Because it can promote C-diff instruct patients to report
increase in stool frequency.
Carbapenems baseline - ANSWER take sample for culture to determine infecting organism
Carbapenems monitoing - ANSWER None. Nothing is recommended.
, NR 568 Midterm Reviewer 117 complete
solutions.
Carbapenems high risk patients - ANSWER history of allergic reaction
patient using valprotate to control seizure should never be given imipenem
Carbapenems evaluation - ANSWER decrease on symptoms like fever, pain, edema and inflammation
Carbapenems minimize adverse effects - ANSWER dosage should be reduced for patients with renal
impairment to prevent toxicity
Vancomycin therapeutic goal - ANSWER Treatment of serious infections, including C-diff, MRSA, and
infections that are caused by susceptible organisms in patients allergic to PCN.
Vanco baseline - ANSWER culture and sensitivity
Vanco monitoring - ANSWER Vanco drug levels should be monitored during IV treatment
Vanco high risk patients - ANSWER patients with renal impairment
Vanco evaluating therapeutic effects - ANSWER monitor for indeication of antimicrobial effects,
including reduction in fever, pain, edema and inflammation.
What do you not administer with Tetracycline? - ANSWER Calcium supplements
MIlk products
Iron supplements
Magnesium-containing laxatives
most antacids (bec of content of magnesium or aluminum)
What do you teach a patient taking Tetracycline? - ANSWER To apply sunscree, protective clothing and
avoid exposure to sunlight because this medication can cause severe sunburn.
